; and (iii) the Federal agency’s routine exercise of the capabilities to perform bioattribution activities. (B) The process by which a bioattribution determination is made by each such Federal agency, including how such process may address national security considerations. (C) Development of assignments, milestones, and timelines necessary to establish the strongest possible national capacity for bioattribution. (D) A plan for the identification, development, and implementation of new technologies, through both internal and public-private initiatives, with an emphasis on diagnostic, sequencing, and safe collection capabilities. (2) Coordination In developing the biological attribution strategy under subsection (b)(11), the Secretary shall coordinate with the relevant Federal agencies, including the Administration for Strategic Preparedness and Response, the Office of Science and Technology Policy, and the Office of the Director of National Intelligence. . 2. Early warning strategy and implementation plan (a) Preparedness goal Section 2802(b) of the Public Health Service Act ( 42 U.S.C. 300hh–1(b) ), as amended by section 1, is further amended by adding at the end the following: (12) Early warning strategy and implementation plan Developing and implementing an early warning strategy and implementation plan for biological, chemical, and radiological threats, in accordance with subsection (d). . (b) Details of strategy and plan Section 2802 of the Public Health Service Act ( 42 U.S.C. 300hh–1 ), as amended by section 1, is further amended by adding at the end the following: (d) Early Warning Strategy and Implementation Plan (1) Objectives The objectives of the early warning strategy and implementation plan under subsection (b)(12) shall include— (A) development of a robust early warning function for the United States which incorporates new technologies, with an emphasis on diagnostic, sequencing, and safe collection capabilities